Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

6,049 total articles

AppLovin Looks Cheap Relative to Growth — Tactical Buy on Pullback

AppLovin Looks Cheap Relative to Growth — Tactical Buy on Pullback

AppLovin (APP) has had a choppy run since its 52-week high, but the company still prints strong profitability metrics and AI-driven product catalysts. With a market cap near $147B and a P/E in the low 40s, the stock looks buyable for a swing trade given recent technical setup and fundamental upside from Axon. Entry at the current levels, a discipli…

Nvidia: Ride the GPU Shortage — Tactical Swing Long Into Earnings

Nvidia: Ride the GPU Shortage — Tactical Swing Long Into Earnings

The GPU capacity squeeze is real and showing up in rental prices and enterprise procurement cycles. Nvidia sits at the center of that bottleneck: high-margin data-center revenue, massive free cash flow and an effective pricing mechanism through OEM and cloud partners. This trade idea takes a tactical long on NVDA into the next 45 trading days, with…

Nvidia: Multiple Compression Is No Compliment - Upgrade to Buy

Nvidia: Multiple Compression Is No Compliment - Upgrade to Buy

Nvidia's business remains the primary beneficiary of the AI infrastructure boom: dominant GPUs, high margins, and huge free cash flow. The stock has pulled back on valuation compression despite continued revenue and cash generation. We upgrade to Buy and lay out an actionable trade plan: enter at $195.00, stop at $170.00, target $320.00 over a flex…

Why I'm Still Long EZCORP — Now It's a Rollup Play Backed by Cash Flow

Why I'm Still Long EZCORP — Now It's a Rollup Play Backed by Cash Flow

Ezcorp's recent deal-making has shifted the investment case from a pure turnaround to a cash-flowing rollup with clear operational optionality. The shares trade at reasonable multiples (EV/EBITDA ~9.8, P/B ~1.71) and the company just pushed to a new 52-week high after consolidating 105 stores into Founders and adding dozens more in Mexico. I rate E…

HPE: Riding AI and Networking Demand — Buy the Strength, Not the Dip

HPE: Riding AI and Networking Demand — Buy the Strength, Not the Dip

Hewlett Packard Enterprise is benefitting from accelerating AI inference and networking demand. Q1 beat and an EPS guide of $2.30-$2.50 make today’s $24s an attractive entry for a mid-term swing trade. Valuation (implied forward P/E ~10x) is reasonable vs. cash flow and leverage metrics; the trade is predicated on continued strength in networking a…

Buy the Dip in Goldman Sachs: Near-Term Fog, Secular Upside Intact

Buy the Dip in Goldman Sachs: Near-Term Fog, Secular Upside Intact

Goldman Sachs faces visible headwinds in the near term - slower deal flow, rate-driven trading normalization, and margin pressure - but its franchise, capital position, and pivot to fee-rich businesses justify a longer-term constructive stance. This trade lays out a concrete entry, stop and target with time horizons and catalysts to watch.

Accenture: Valuation Edge and AI Muscle Make it Worth a Re-rating

Accenture: Valuation Edge and AI Muscle Make it Worth a Re-rating

Accenture is a lower-risk way to play enterprise AI adoption and managed services. The stock has been punished despite healthy cash flow, a modest debt load, and ongoing AI investments. At roughly $117.6B market cap and a P/E near 15.5, the risk/reward favors a long position with a clear stop and a target that assumes a modest multiple re-rating al…

Why Novo Nordisk May Face Further Downside as the GLP-1 Fight Intensifies

Why Novo Nordisk May Face Further Downside as the GLP-1 Fight Intensifies

Novo Nordisk sits at the center of an increasingly binary GLP-1 fight. Eli Lilly's recent drug approvals and a stronger clinical edge for some pipeline assets increase the odds of market-share losses; Novo's valuation looks reasonable on paper but may not price in near-term revenue pressure. This trade idea proposes a mid-term short to capture furt…

Volkswagen: Execution Visibility Is Improving — Buy Confirmed

Volkswagen: Execution Visibility Is Improving — Buy Confirmed

Volkswagen ADR (VWAGY) offers an asymmetric setup: a $53.7B market cap, single-digit P/E (7.0), and a 4.3% dividend yield priced into a stock that is bottoming technically. With positive MACD momentum, rising short interest that could fuel squeezes, and tangible progress on partnerships and software monetization, we prefer a tactical long. Entry, s…

Buy Credo (CRDO): Acquisition and Momentum Make the Bear Case Stale

Buy Credo (CRDO): Acquisition and Momentum Make the Bear Case Stale

Credo is executing into the AI connectivity upgrade cycle. The DustPhotonics acquisition, blistering revenue growth and strong margins remove the worst of the bear arguments. This is a tactical-to-position trade: enter on strength or small pullback, protect with a defined stop, and ride a re-rating as optical revenue and AEC momentum compound.

CME Group: Buy the Yield, Hold for Volatility-Driven Upside

CME Group: Buy the Yield, Hold for Volatility-Driven Upside

CME Group (CME) offers a rare combination for income-oriented investors: a high-quality exchange operator with $4.2B in free cash flow last year, a $7.45 per-share distribution that yields about 3.7% at current prices, and a business that benefits when markets get choppy. I like a position-sized, dividend-focused long at current levels with a clear…